Developer docs
API playgroundTry for free, no card

Search company profiles

NovaVision

Full company profile

uuid000snna

Namestring
NovaVision
Legal namestring
NovaVision, Inc.
Websiteurl
novavision.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

NovaVision Inc. is a private digital therapeutics company headquartered in Boca Raton, Florida, that develops FDA-cleared and FDA-registered therapies for neurological vision loss resulting from stroke or brain injury. The company operates as the vision rehabilitation division of Vycor Medical and serves patients who have suffered neurological damage causing hemianopia, quadrantanopia, scotoma, or other visual field deficits. Its portfolio includes Vision Restoration Therapy (VRT), described as the only FDA-cleared therapy for restoring neurological vision loss, which uses repeated light stimulation at the border of intact and damaged visual fields; NeuroEyeCoach, an FDA-registered compensatory eye movement training program with self-adaptive difficulty; and VIDIT, a diagnostic system for clinical visual field screening. The underlying platform combines High-Resolution Perimetry for diagnostic mapping, cloud-connected patient portals for progress monitoring, and PC-based software for at-home therapy delivery.

The company's business model is primarily direct-to-consumer one-time license sales, with a Therapy Suite combining VRT and NeuroEyeCoach priced at $900-$950, NeuroEyeCoach standalone at $450, and a VRT extension module at $300. A freemium online vision screening test serves as lead generation, while two B2B channels — the NovaVision Pro Physician Model and the NovaVision Center Model — distribute the products through physician prescriptions and rehabilitation clinics. The company reports serving patients in the US, Canada, UK, Germany, and Australia, supported by a German partner company, and markets directly via its website, social channels, and patient testimonials. Therapies are not generally covered by health insurance or Medicare/Medicaid, though the company notes some patients achieve reimbursement with documentation. The company is small (11-50 employees), has no disclosed external funding rounds, and relies on the corporate resources of parent Vycor Medical.

Short descriptiontext

NovaVision Inc., a Boca Raton-based division of Vycor Medical, develops FDA-cleared digital therapeutics (VRT and NeuroEyeCoach) that restore or compensate for neurological vision loss in stroke and brain injury patients, selling directly to patients, physicians, and rehabilitation clinics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoca Raton, United States
HQ citystring
Boca Raton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vision restoration therapy, neurological vision rehabilitation, digital therapeutics, FDA-cleared therapy, stroke vision recovery
Industry4 codes
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAKAKAJ
Low Vision Rehabilitation
SECONDARYHLAKAKAM
Vision Therapy & Orthoptics
SECONDARYHLAKAKAH
Neuro-Ophthalmology
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Digital Therapeutics for Neurological Vision Rehabilitation
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1VRT & NeuroEyeCoach Therapy Suite
TypeOne Time License
Description

Combined therapy suite providing 6 months of VRT plus complete 36 sessions of NeuroEyeCoach for $950. Includes $50 refundable chinrest deposit (US) or $165 purchase price (outside US). This is the primary revenue stream representing best value for comprehensive vision rehabilitation.

novavision.com
2NeuroEyeCoach Standalone
TypeOne Time License
Description

Complete 36 sessions of NeuroEyeCoach Program available separately for $450. For patients who have not suffered vision loss but have eye movement problems, or as follow-on after VRT completion.

novavision.com
3VRT Extension Module
TypeOne Time License
Description

3 additional months of VRT available for $300 one-time. For patients who show continued improvement and benefit from extended therapy beyond initial 6-month program.

novavision.com
4Online Vision Screening Test
TypeFreemium
Description

Free online visual field screening test to help identify potential vision loss after stroke or brain injury. Serves as lead generation tool driving patient acquisition for paid therapy programs.

novavision.com
5Chinrest Hardware
TypeHardware Sales
Description

Chinrest required for VRT therapy - $50 refundable deposit in US, $165 purchase price outside US. NovaVision covers mainland USA shipping costs.

novavision.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Pricing details4 tiers
1VRT & NeuroEyeCoach Therapy Suite - Best Value at $950
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

$950 one-time payment includes 6 months of VRT therapy plus complete 36 sessions of NeuroEyeCoach. $50 refundable deposit required for chinrest in US; $165 chinrest purchase price outside US. NovaVision covers mainland USA shipping.

novavision.com
2NeuroEyeCoach Standalone - $450
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Complete 36 sessions of NeuroEyeCoach Program available separately. For patients with eye movement problems without vision loss, or for use independently.

novavision.com
3VRT Extension Module - $300
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

3 additional months of VRT therapy for patients showing continued improvement. Contact Patient Services at 888.205.0800 to extend.

novavision.com
4Free Online Vision Screening Test
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free vision test designed to help determine if neurological vision loss has occurred after stroke or brain injury. Provides instant preliminary results. Not a diagnostic tool - should be combined with complete vision evaluation with medical professional.

novavision.com
GTM typeB2C
B2C
Offering typeSoftware
Software
Core offering1 text field

NovaVision develops and sells FDA-cleared and FDA-registered digital therapeutics that rehabilitate neurological vision loss caused by stroke or brain injury. Its portfolio includes Vision Restoration Therapy (VRT) — the only commercially available FDA-cleared therapy designed to restore lost vision through neuroplasticity-based light stimulation — and NeuroEyeCoach, a self-adaptive computer-based program for compensatory eye movement training. Therapies are delivered via PC software at home, supplemented by VIDIT diagnostic hardware, HRP perimetry, online screening, and professional physician/clinic portals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 70%+ of VRT patients show measurable visual field improvements
+3 more records
Product overview1 text field

NovaVision offers a portfolio of FDA cleared and registered therapies and diagnostic products for vision disorders resulting from stroke or brain injury. The core offerings include Vision Restoration Therapy (VRT) - the only commercially available FDA-cleared therapy for restoring neurological vision loss - and NeuroEyeCoach, a systematic eye movement training program. These are provided individually, as a combined Therapy Suite ($900), and through professional models for physicians and clinics. Supporting products include VIDIT diagnostic system and an Online Visual Field Screening Test.

Product and service9 records
1Vision Restoration Therapy (VRT)
CategoryVision Restoration Therapy
Description

The only FDA-cleared therapy designed to restore vision loss due to neurological brain damage from stroke or brain injury. Uses repeated light stimulus exercises at the border between intact and damaged visual fields to strengthen the brain's visual processing ability. Performed twice daily, six days a week for six months at home on the patient's computer under physician prescription.

2NeuroEyeCoach
CategoryVision Compensation Therapy
Description

FDA-registered home-based, computer-based compensatory eye movement training program for stroke and brain injury patients. Trains users to scan their environment more efficiently through visual search tasks with 12 self-adaptive difficulty levels and 36 total sessions. Designed to help patients make the most of remaining vision.

3VIDIT Diagnostic System
CategoryVision Diagnostic System
Description

Diagnostic system enabling therapists and clinicians to perform high-resolution 7-minute visual field tests to screen for central visual field deficits by campimetric testing of the central 20 degrees visual field. Designed for use in rehabilitation centers and clinics.

4NovaVision Online Visual Field Screening Test
CategoryVision Screening / Lead Generation
Description

Free online vision test designed to help determine whether someone has experienced neurological vision loss after stroke or brain injury. Provides instant preliminary results and can be performed at home; serves as a funnel into NovaVision's paid therapy programs.

5NovaVision Therapy Suite (VRT + NeuroEyeCoach bundle)
CategoryTherapy Bundle
Description

Combined therapy package offering both VRT and NeuroEyeCoach together for $950, providing 6 months of VRT plus complete 36 sessions of NeuroEyeCoach to maximize patient benefit through complementary restoration and compensation approaches.

6VRT Extension Module
CategoryTherapy Add-On
Description

3 additional months of Vision Restoration Therapy available as a one-time purchase for patients who show continued improvement beyond the initial 6-month program. Contact Patient Services at 888.205.0800 to extend.

7NovaVision Center Model
CategoryProfessional / Clinic Program
Description

A program designed for clinics and rehabilitation centers to provide vision diagnosis and rehabilitation using the VIDIT diagnostic system and NeuroEyeCoach therapy, offered at affordable and flexible pricing for in-clinic use.

8NovaVision Pro Physician Model
CategoryProfessional / Physician Program
Description

A physician practice offering enabling doctors to register patients for NovaVision therapies and monitor their progress through a dedicated portal, with software, manuals, marketing materials, and technical support provided.

9NovaVision Chinrest
CategoryTherapy Hardware Accessory
Description

Required hardware chinrest accessory used to standardize patient head position during VRT therapy sessions at home. $50 refundable deposit within the US; $165 purchase price outside the US. NovaVision covers mainland USA shipping.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOthers
Description

NovaVision is the vision rehabilitation division of Vycor Medical. NovaVision operates as a subsidiary or division leveraging Vycor Medical's corporate infrastructure and resources for the neurological vision therapy business.

2German Partner Company
Strategic tierMinorTypeOthers
Description

NovaVision has a partner company in Germany supporting European operations and potentially European regulatory/commercial activities.

novavision.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Posit Science develops BrainHQ, an evidence-based digital therapeutic for cognitive and brain training. Like NovaVision, it operates clinically validated neuro-rehabilitation software sold direct and through clinical channels in the post-stroke / brain injury population.

TypeDirect peer
Description

RightEye uses eye-tracking-based vision assessments to detect neurological issues such as concussion and stroke-related deficits. It targets a similar neurology / brain-injury population with vision diagnostics, directly overlapping NovaVision's VIDIT and NeuroEyeCoach.

TypeDirect peer
Description

LumiThera develops the FDA-cleared Valeda Light Delivery System, a photobiomodulation device to treat ocular diseases including dry AMD. Comparable to NovaVision in applying light-based neuro-ophthalmic therapies with FDA-cleared/registered devices.

TypeDirect peer
Description

MindMaze, including the SyncThink platform, uses eye-tracking to assess and treat brain injury and neurological conditions. It overlaps NovaVision in serving post-stroke and TBI populations with technology-driven visual assessments and digital therapies.

TypeEmerging player
Description

Constant Therapy delivers digital speech, language, and cognitive therapy to stroke survivors. Adjacent to NovaVision in providing clinically validated digital neuro-rehabilitation sold to patients and clinics post-stroke.

TypeDirect peer
Description

Vispero, parent of Optelec, Enhanced Vision, and Freedom Scientific, is a leading manufacturer of low-vision aids and assistive technology. Comparable to NovaVision as a vendor of vision rehabilitation solutions to patients with visual impairment.

TypeDirect peer
Description

HumanWare manufactures assistive technologies for people with visual impairments, including electronic magnifiers, braille devices, and low-vision solutions. Comparable to NovaVision in addressing functional vision needs of vision-impaired patients through specialized products.

TypeBroad incumbent
Description

Bioness, a Bioventus company, develops electrical stimulation devices for neurological and orthopedic rehabilitation. Comparable as a broader neuro-rehab device incumbent serving stroke recovery with neuromodulation products.

TypeBroad incumbent
Description

Tobii is a global leader in eye-tracking technology with applications in medical diagnostics, including neurological assessment. Comparable as a broad technology incumbent enabling vision and neurology assessments overlapping NovaVision's diagnostic platform.

10Carl Zeiss Meditec
TypeBroad incumbent
Description

Carl Zeiss Meditec manufactures ophthalmic diagnostic and surgical devices (OCT, perimeters, fundus cameras) used in vision assessments. Comparable as a broad medical device incumbent in the ophthalmic diagnostic space where NovaVision's VIDIT diagnostic operates.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NovaVision

Digital Therapeutics for Neurological Vision Rehabilitationnovavision.com

NovaVision Inc., a Boca Raton-based division of Vycor Medical, develops FDA-cleared digital therapeutics (VRT and NeuroEyeCoach) that restore or compensate for neurological vision loss in stroke and brain injury patients, selling directly to patients, physicians, and rehabilitation clinics.

What NovaVision does

NovaVision Inc. is a private digital therapeutics company headquartered in Boca Raton, Florida, that develops FDA-cleared and FDA-registered therapies for neurological vision loss resulting from stroke or brain injury. The company operates as the vision rehabilitation division of Vycor Medical and serves patients who have suffered neurological damage causing hemianopia, quadrantanopia, scotoma, or other visual field deficits. Its portfolio includes Vision Restoration Therapy (VRT), described as the only FDA-cleared therapy for restoring neurological vision loss, which uses repeated light stimulation at the border of intact and damaged visual fields; NeuroEyeCoach, an FDA-registered compensatory eye movement training program with self-adaptive difficulty; and VIDIT, a diagnostic system for clinical visual field screening. The underlying platform combines High-Resolution Perimetry for diagnostic mapping, cloud-connected patient portals for progress monitoring, and PC-based software for at-home therapy delivery.

The company's business model is primarily direct-to-consumer one-time license sales, with a Therapy Suite combining VRT and NeuroEyeCoach priced at $900-$950, NeuroEyeCoach standalone at $450, and a VRT extension module at $300. A freemium online vision screening test serves as lead generation, while two B2B channels — the NovaVision Pro Physician Model and the NovaVision Center Model — distribute the products through physician prescriptions and rehabilitation clinics. The company reports serving patients in the US, Canada, UK, Germany, and Australia, supported by a German partner company, and markets directly via its website, social channels, and patient testimonials. Therapies are not generally covered by health insurance or Medicare/Medicaid, though the company notes some patients achieve reimbursement with documentation. The company is small (11-50 employees), has no disclosed external funding rounds, and relies on the corporate resources of parent Vycor Medical.

NovaVision firmographics

Firmographics
Name
NovaVision
Legal name
NovaVision, Inc.
Website
https://novavision.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
11–50 employees
Short description
NovaVision Inc., a Boca Raton-based division of Vycor Medical, develops FDA-cleared digital therapeutics (VRT and NeuroEyeCoach) that restore or compensate for neurological vision loss in stroke and brain injury patients, selling directly to patients, physicians, and rehabilitation clinics.
Ownership category
akta.pro rank

NovaVision industry classification

Industry
Product category
Digital Therapeutics for Neurological Vision Rehabilitation
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAKAKAJ
Low Vision Rehabilitation
SECONDARYHLAKAKAM
Vision Therapy & Orthoptics
SECONDARYHLAKAKAH
Neuro-Ophthalmology

Keywords

  • Vision restoration therapy
  • Neurological vision rehabilitation
  • Digital therapeutics
  • FDA-cleared therapy
  • Stroke vision recovery

Where NovaVision is headquartered

Location

Headquarters

HQ city
Boca Raton
HQ country
United States
HQ region
North America

Offices2 records

Markets served

NovaVision business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

  1. VRT & NeuroEyeCoach Therapy Suite: Combined therapy suite providing 6 months of VRT plus complete 36 sessions of NeuroEyeCoach for $950. Includes $50 refundable chinrest deposit (US) or $165 purchase price (outside US). This is the primary revenue stream representing best value for comprehensive vision rehabilitation.
  2. NeuroEyeCoach Standalone: Complete 36 sessions of NeuroEyeCoach Program available separately for $450. For patients who have not suffered vision loss but have eye movement problems, or as follow-on after VRT completion.
  3. VRT Extension Module: 3 additional months of VRT available for $300 one-time. For patients who show continued improvement and benefit from extended therapy beyond initial 6-month program.
  4. Online Vision Screening Test: Free online visual field screening test to help identify potential vision loss after stroke or brain injury. Serves as lead generation tool driving patient acquisition for paid therapy programs.
  5. Chinrest Hardware: Chinrest required for VRT therapy - $50 refundable deposit in US, $165 purchase price outside US. NovaVision covers mainland USA shipping costs.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractVRT & NeuroEyeCoach Therapy Suite - Best Value at $950
One time/ perpetual licensePay-as-you-goNeuroEyeCoach Standalone - $450
One time/ perpetual licensePay-as-you-goVRT Extension Module - $300
FreemiumPay-as-you-goFree Online Vision Screening Test

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

NovaVision product offering

Product offering

Core offering

NovaVision develops and sells FDA-cleared and FDA-registered digital therapeutics that rehabilitate neurological vision loss caused by stroke or brain injury. Its portfolio includes Vision Restoration Therapy (VRT) — the only commercially available FDA-cleared therapy designed to restore lost vision through neuroplasticity-based light stimulation — and NeuroEyeCoach, a self-adaptive computer-based program for compensatory eye movement training. Therapies are delivered via PC software at home, supplemented by VIDIT diagnostic hardware, HRP perimetry, online screening, and professional physician/clinic portals.

Product overview

NovaVision offers a portfolio of FDA cleared and registered therapies and diagnostic products for vision disorders resulting from stroke or brain injury. The core offerings include Vision Restoration Therapy (VRT) - the only commercially available FDA-cleared therapy for restoring neurological vision loss - and NeuroEyeCoach, a systematic eye movement training program. These are provided individually, as a combined Therapy Suite ($900), and through professional models for physicians and clinics. Supporting products include VIDIT diagnostic system and an Online Visual Field Screening Test.

Differentiator

Problem solved

Functional benefit

Products and services

  • Vision Restoration Therapy (VRT) The only FDA-cleared therapy designed to restore vision loss due to neurological brain damage from stroke or brain injury. Uses repeated light stimulus exercises at the border between intact and damaged visual fields to strengthen the brain's visual processing ability. Performed twice daily, six days a week for six months at home on the patient's computer under physician prescription.
  • NeuroEyeCoach FDA-registered home-based, computer-based compensatory eye movement training program for stroke and brain injury patients. Trains users to scan their environment more efficiently through visual search tasks with 12 self-adaptive difficulty levels and 36 total sessions. Designed to help patients make the most of remaining vision.
  • VIDIT Diagnostic System Diagnostic system enabling therapists and clinicians to perform high-resolution 7-minute visual field tests to screen for central visual field deficits by campimetric testing of the central 20 degrees visual field. Designed for use in rehabilitation centers and clinics.
  • NovaVision Online Visual Field Screening Test Free online vision test designed to help determine whether someone has experienced neurological vision loss after stroke or brain injury. Provides instant preliminary results and can be performed at home; serves as a funnel into NovaVision's paid therapy programs.
  • NovaVision Therapy Suite (VRT + NeuroEyeCoach bundle) Combined therapy package offering both VRT and NeuroEyeCoach together for $950, providing 6 months of VRT plus complete 36 sessions of NeuroEyeCoach to maximize patient benefit through complementary restoration and compensation approaches.
  • VRT Extension Module 3 additional months of Vision Restoration Therapy available as a one-time purchase for patients who show continued improvement beyond the initial 6-month program. Contact Patient Services at 888.205.0800 to extend.
  • NovaVision Center Model A program designed for clinics and rehabilitation centers to provide vision diagnosis and rehabilitation using the VIDIT diagnostic system and NeuroEyeCoach therapy, offered at affordable and flexible pricing for in-clinic use.
  • NovaVision Pro Physician Model A physician practice offering enabling doctors to register patients for NovaVision therapies and monitor their progress through a dedicated portal, with software, manuals, marketing materials, and technical support provided.
  • NovaVision Chinrest Required hardware chinrest accessory used to standardize patient head position during VRT therapy sessions at home. $50 refundable deposit within the US; $165 purchase price outside the US. NovaVision covers mainland USA shipping.

Quantifiable outcome

  • 70%+ of VRT patients show measurable visual field improvements
  • +3 more outcomes

Companies that use NovaVision

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

NovaVision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

NovaVision partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Vycor Medical (Parent Company)coreOthersNovaVision is the vision rehabilitation division of Vycor Medical. NovaVision operates as a subsidiary or division leveraging Vycor Medical's corporate infrastructure and resources for the neurological vision therapy business.
  • German Partner CompanyminorOthersNovaVision has a partner company in Germany supporting European operations and potentially European regulatory/commercial activities.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

NovaVision competitors and assessment

Company assessment

Direct peers

  • Posit Science: Posit Science develops BrainHQ, an evidence-based digital therapeutic for cognitive and brain training. Like NovaVision, it operates clinically validated neuro-rehabilitation software sold direct and through clinical channels in the post-stroke / brain injury population.
  • RightEye: RightEye uses eye-tracking-based vision assessments to detect neurological issues such as concussion and stroke-related deficits. It targets a similar neurology / brain-injury population with vision diagnostics, directly overlapping NovaVision's VIDIT and NeuroEyeCoach.
  • LumiThera: LumiThera develops the FDA-cleared Valeda Light Delivery System, a photobiomodulation device to treat ocular diseases including dry AMD. Comparable to NovaVision in applying light-based neuro-ophthalmic therapies with FDA-cleared/registered devices.
  • MindMaze (SyncThink): MindMaze, including the SyncThink platform, uses eye-tracking to assess and treat brain injury and neurological conditions. It overlaps NovaVision in serving post-stroke and TBI populations with technology-driven visual assessments and digital therapies.
  • Vispero (Optelec): Vispero, parent of Optelec, Enhanced Vision, and Freedom Scientific, is a leading manufacturer of low-vision aids and assistive technology. Comparable to NovaVision as a vendor of vision rehabilitation solutions to patients with visual impairment.
  • HumanWare: HumanWare manufactures assistive technologies for people with visual impairments, including electronic magnifiers, braille devices, and low-vision solutions. Comparable to NovaVision in addressing functional vision needs of vision-impaired patients through specialized products.

Emerging players

  • Constant Therapy Health: Constant Therapy delivers digital speech, language, and cognitive therapy to stroke survivors. Adjacent to NovaVision in providing clinically validated digital neuro-rehabilitation sold to patients and clinics post-stroke.

Broad incumbents

  • Bioness (Bioventus): Bioness, a Bioventus company, develops electrical stimulation devices for neurological and orthopedic rehabilitation. Comparable as a broader neuro-rehab device incumbent serving stroke recovery with neuromodulation products.
  • Tobii: Tobii is a global leader in eye-tracking technology with applications in medical diagnostics, including neurological assessment. Comparable as a broad technology incumbent enabling vision and neurology assessments overlapping NovaVision's diagnostic platform.
  • Carl Zeiss Meditec: Carl Zeiss Meditec manufactures ophthalmic diagnostic and surgical devices (OCT, perimeters, fundus cameras) used in vision assessments. Comparable as a broad medical device incumbent in the ophthalmic diagnostic space where NovaVision's VIDIT diagnostic operates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

NovaVision social profiles

Digital presence

NovaVision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NovaVision leadership team

Management profile

Number of profiles

NovaVision funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NovaVision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NovaVision

What does NovaVision do?

NovaVision develops and sells FDA-cleared and FDA-registered digital therapeutics that rehabilitate neurological vision loss caused by stroke or brain injury. Its portfolio includes Vision Restoration Therapy (VRT) — the only commercially available FDA-cleared therapy designed to restore lost vision through neuroplasticity-based light stimulation — and NeuroEyeCoach, a self-adaptive computer-based program for compensatory eye movement training. Therapies are delivered via PC software at home, supplemented by VIDIT diagnostic hardware, HRP perimetry, online screening, and professional physician/clinic portals.

Is NovaVision a public or private company?

NovaVision is a private company. It is classified as corporate owned and is currently operating.

When was NovaVision founded?

NovaVision was founded in 1998. It employs 11 to 50 people.

Where is NovaVision based?

NovaVision is headquartered in Boca Raton, United States, in the North America region.

How does NovaVision make money?

Five revenue lines are on record. VRT & NeuroEyeCoach Therapy Suite is the primary driver. The others are neuroEyeCoach Standalone, VRT Extension Module, online Vision Screening Test and chinrest Hardware.

Who are NovaVision's main competitors?

Direct peers on record are Posit Science, RightEye, LumiThera, MindMaze (SyncThink), Vispero (Optelec) and HumanWare. Constant Therapy Health is listed as an emerging player. Broad incumbents are Bioness (Bioventus), Tobii and Carl Zeiss Meditec.

Does NovaVision have an API?

No public API is recorded for NovaVision.

What industry is NovaVision in?

NovaVision's product category is Digital Therapeutics for Neurological Vision Rehabilitation. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLAKAKAJ, Low Vision Rehabilitation. Its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StarfishmedicalVision Restoration Therapy DeviceStarFish developed a portable home-use device utilizing NovaVision’s VRT therapy technology to improve patients' visual field range and sensitivity. The device employs repetitive light stimulation to activate impaired visual functions in transition zones, strengthening residual vision and neuronal networks.PR NewswireNew Clinical Study on NeuroEyeCoach Conclusively Supports Meaningful Improvement in Eye Movement EfficiencyA peer-reviewed study published in BioMed Research International by researchers from University of Aberdeen, University of Verona, and University of Munich validates NovaVision's NeuroEyeCoach for patients with homonymous visual field loss, showing improved visual search times, reduced errors, and better daily living activities within 2-3 weeks. Vycor Medical, which owns NovaVision, announced the findings, with CEO Peter Zachariou emphasizing the study's rigorous analysis underscores the therapy's merits for patients with vision disorders from neurological brain damage. The NeuroEyeCoach is a compensatory therapy (not restorative) that represents the first evidence-based gold-standard registered medical device accessible to patients at home or in clinical settings for this purpose.GlobeNewswireCEO of Vycor Medical, Inc. (VYCO) Discusses Recent Agreement With HealthSouth for NovaVision's NeuroEyeCoach Eye Compensation TherapyVycor Medical CEO Peter Zachariou discussed a new HealthSouth agreement making NovaVision's VIDIT diagnostic and NeuroEyeCoach compensation therapy available to HealthSouth hospitals. The company cites a $4 billion US and European market potential and plans to expand to other rehabilitation chains.GlobeNewswireVycor's NovaVision Unit Announces the Commercial Release of NeuroEyeCoach(TM) -- A Novel Saccadic Eye Training TherapyVycor's subsidiary NovaVision launched NeuroEyeCoach, a saccadic eye training therapy, for commercial release in the U.S. The program targets over 8 million Americans with stroke-related visual disorders and is delivered via the Internet. NovaVision plans to combine it with its Vision Restoration Therapy in a single therapy suite.